BlackRock Updates Passive Stake in Medpace Holdings (MEDP)
Ticker: MEDP · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1668397
| Field | Detail |
|---|---|
| Company | Medpace Holdings, Inc. (MEDP) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock just updated its passive stake in Medpace, showing continued institutional interest.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating its ownership of Medpace Holdings, Inc. common stock as of December 31, 2023. This filing, Amendment No. 7, updates previous disclosures about BlackRock's passive investment in Medpace. For investors, this matters because BlackRock is a major institutional investor, and changes in its holdings can signal confidence or concern in the stock, though this specific filing is an update to an existing position.
Why It Matters
This filing confirms BlackRock's continued significant, albeit passive, investment in Medpace Holdings, Inc., which can reassure investors about institutional confidence in the company.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor and does not indicate any immediate new risks or opportunities.
Analyst Insight
Investors should note BlackRock's continued passive stake in Medpace Holdings, Inc. as a sign of ongoing institutional interest, but this filing alone doesn't suggest a need for immediate action.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Medpace Holdings, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G/A
- 58506Q109 (other) — the CUSIP number for Medpace Holdings Inc. Common Stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and '(Amendment No: 7)' in the filing.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as stated under '(1)Names of reporting persons. BlackRock, Inc.' and in the 'FILED BY' section of the filing.
What is the subject company whose securities are being reported?
The subject company is Medpace Holdings, Inc., as identified under 'SUBJECT COMPANY: COMPANY CONFORMED NAME: Medpace Holdings, Inc.' and '(Name of Issuer) Medpace Holdings Inc' in the filing.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Common Stock of Medpace Holdings, Inc. is 58506Q109, as listed under '(CUSIP Number) 58506Q109' in the filing.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as stated under '(Date of Event Which Requires Filing of this Statement) December 31, 2023'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding Medpace Holdings, Inc. (MEDP).